CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 166 enrolled
Drug / intervention
Metformindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01873859
NCT01873859N/ACompleted
CompareCT.gov

Incidence of Lactic Acidosis After Coronary Angiography and Angioplasty in Diabetic Patients on Continued Metformin Therapy With Normal Renal Function.

Shahid Beheshti University of Medical Sciences·interventional·Posted Jun 10, 2013·Updated Jun 16, 2014

In Brief

A clinical study evaluating Metformin for Diabetes Mellitus and Lactic Acidosis. Completed, enrolled 166 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether metformin causes lactic acidosis in diabetic patients with preserved kidney function, undergoing coronary angiography or angioplasty with new contrast media. In other words is it necessary to discontinue metformin before these procedures, even when Iodixanol is used as contrast media, which is isosmolar agent and much more safer than urografin which was the main agent in the previous studies that were the base of present guidelines?

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Lactic Acidosis
CountriesIran
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 10, 2013
Enrollment StartMay 1, 2013
Primary CompletionFeb 1, 2014
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.1 years ago

Interventions

Metformindrug

Incidence of lactic acidosis in diabetic patients receiving contrast media in the presence of metformin.